Spyre Therapeutics, Inc. (SYRE) — Institutional Holders, Q2 2026

269 institutional investment managers reported a SYRE position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $8.5B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

SYRE in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

89

Added to

102

Trimmed

58

Sold out

21

Biggest buyers

  1. Paradigm Biocapital AdvisorsAdded · +1,883,512 sh+$167.2M
  2. VANGUARD PORTFOLIO MANAGEMENTAdded · +1,744,968 sh+$154.9M
  3. ADAGE CAPITAL PARTNERS GP, L.L.C.New · +1,722,300 sh+$152.9M
  4. Capital World InvestorsAdded · +1,648,989 sh+$146.4M
  5. PRICE T ROWE ASSOCIATESAdded · +1,362,125 sh+$120.9M

Biggest sellers

  1. Fairmount Funds ManagementSold out · -4,018,101 sh-$356.7M
  2. RA CAPITAL MANAGEMENT, L.P.Sold out · -1,621,620 sh-$144.0M
  3. Commodore CapitalTrimmed · -1,065,594 sh-$94.6M
  4. BAKER BROS. ADVISORSSold out · -1,000,000 sh-$88.8M
  5. Caligan PartnersSold out · -878,127 sh-$78.0M

SYRE 13F holders ranked 1–100 of 269

Institutional investors reporting a position in Spyre Therapeutics, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
FMR#1 · 13,026,187 sh$1.2B+10.6%
BlackRock#2 · 6,506,605 sh$577.7M+17.8%
PERCEPTIVE ADVISORS#3 · 4,319,496 sh$383.5M+14.2%
RTW INVESTMENTS#4 · 4,251,996 sh$377.5M+1.9%
Paradigm Biocapital Advisors#5 · 3,840,778 sh$341.0M+96.2%
VANGUARD CAPITAL MANAGEMENT#6 · 3,448,681 sh$306.2M+12.8%
STATE STREET#7 · 3,057,416 sh$271.4M+17.3%
VR Adviser#8 · 2,985,448 sh$265.0M-19.0%
PRICE T ROWE ASSOCIATES#9 · 2,960,855 sh$262.9M+85.2%
DRIEHAUS CAPITAL MANAGEMENT#10 · 2,799,166 sh$248.5M+0.3%
GEODE CAPITAL MANAGEMENT#11 · 2,562,265 sh$239.3M+48.9%
VANGUARD PORTFOLIO MANAGEMENT#12 · 2,330,098 sh$206.9M+298.2%
Capital World Investors#13 · 2,315,553 sh$205.6M+247.4%
Jupiter Topco#14 · 2,206,936 sh$195.9M—
TCG Crossover Management#15 · 1,900,582 sh$168.7M0.0%
TANG CAPITAL MANAGEMENT#16 · 1,892,200 sh$168.0M0.0%
BANK OF AMERICA#17 · 1,777,854 sh$157.8M+44.8%
ADAGE CAPITAL PARTNERS GP, L.L.C.#18 · 1,722,300 sh$152.9MNew
WELLINGTON MANAGEMENT GROUP LLP#19 · 1,581,505 sh$140.4M-13.3%
GOLDMAN SACHS GROUP#20 · 1,478,059 sh$131.2M+447.6%
FRANKLIN RESOURCES#21 · 1,472,943 sh$130.8M+66.8%
Remedium Capital Partners#22 · 1,464,169 sh$130.0M-23.2%
Affinity Asset Advisors#23 · 1,279,134 sh$113.6M0.0%
JPMORGAN CHASE#24 · 1,093,026 sh$98.9M+11.6%
Holocene Advisors#25 · 1,015,170 sh$90.1MNew
MARSHALL WACE, LLP#26 · 991,693 sh$88.0M+612.1%
Polar Capital Plc#27 · 988,009 sh$87.7M+24.6%
Siren, L.L.C.#28 · 968,598 sh$86.0M+18.3%
Capital International Investors#29 · 955,196 sh$84.8M-45.3%
BRAIDWELL#30 · 879,467 sh$78.1M-5.7%
Commodore Capital#31 · 846,786 sh$75.2M-55.7%
UBS Group AG#32 · 843,071 sh$74.8M+25.6%
NORTHERN#33 · 674,529 sh$59.9M+16.5%
CHARLES SCHWAB INVESTMENT MANAGEMENT#34 · 652,958 sh$58.0M+16.0%
Pictet Asset Management Holding SA#35 · 628,138 sh$55.8M+27.8%
EMERALD ADVISERS#36 · 567,430 sh$50.4M-7.5%
VICTORY CAPITAL MANAGEMENT#37 · 553,980 sh$49.2M+89.6%
VANGUARD FIDUCIARY#38 · 551,389 sh$49.0M+18.7%
Candriam S.C.A.#39 · 546,312 sh$48.5M-10.5%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#40 · 522,071 sh$46.3M+151.8%
MORGAN STANLEY#41 · 499,963 sh$44.4M+102.6%
VOYA INVESTMENT MANAGEMENT#42 · 431,694 sh$38.3M+699.9%
EMERALD MUTUAL FUND ADVISERS#43 · 401,271 sh$35.6M-1.7%
SAMLYN CAPITAL#44 · 400,075 sh$35.5M+0.9%
AMERIPRISE FINANCIAL#45 · 356,082 sh$31.6M+123.6%
Integral Health Asset Management#46 · 325,000 sh$28.9MNew
Woodline Partners#47 · 306,049 sh$27.2M+15.1%
JENNISON ASSOCIATES#48 · 303,180 sh$26.9MNew
ADAR1 Capital Management#49 · 283,982 sh$25.2M-16.1%
BNP PARIBAS FINANCIAL MARKETS#50 · 259,923 sh$23.1M+1295.2%
Bank of New York Mellon#51 · 245,193 sh$21.8M+28.1%
Bellevue Group AG#52 · 229,931 sh$20.4MNew
Cormorant Asset Management#53 · 225,000 sh$20.0MNew
SEVEN GRAND MANAGERS#54 · 225,000 sh$20.0M+125.0%
EVENTIDE ASSET MANAGEMENT#55 · 201,616 sh$17.9MNew
MILLENNIUM MANAGEMENT#56 · 196,712 sh$17.5M+34.1%
ORBIMED ADVISORS#57 · 186,145 sh$16.5MNew
FRONTIER CAPITAL MANAGEMENT#58 · 182,931 sh$16.2MNew
Nuveen#59 · 181,105 sh$16.1M+17.7%
Neuberger Berman Group#60 · 180,884 sh$16.1MNew
DEUTSCHE BANK AG\#61 · 174,459 sh$15.5M+35.0%
Universal- Beteiligungs- und Servicegesellschaft mbH#62 · 172,923 sh$15.4M+1.5%
BALYASNY ASSET MANAGEMENT L.P.#63 · 147,042 sh$13.1M+165.1%
Soleus Capital Management, L.P.#64 · 147,000 sh$13.1MNew
Squarepoint Ops#65 · 139,605 sh$12.4MNew
ARMISTICE CAPITAL#66 · 137,588 sh$12.2M+13.8%
Russell Investments Group, Ltd.#67 · 134,757 sh$12.0M+1256.9%
Ensign Peak Advisors#68 · 126,620 sh$11.2M-14.8%
Invesco Ltd.#69 · 120,541 sh$10.7M-9.0%
Blackstone#70 · 120,177 sh$10.7M-59.0%
Rhenman & Partners Asset Management AB#71 · 119,300 sh$10.6MNew
TD ASSET MANAGEMENT#72 · 115,990 sh$10.3M-15.6%
Swiss National Bank#73 · 112,500 sh$10.0M+16.6%
StemPoint Capital#74 · 106,926 sh$9.5M-36.2%
MANUFACTURERS LIFE INSURANCE COMPANY, THE#75 · 104,516 sh$9.3M-7.4%
CITADEL ADVISORS#76 · 103,100 sh$9.2M-4.7%
Boxer Capital Management#77 · 100,000 sh$8.9MNew
RHUMBLINE ADVISERS#78 · 94,763 sh$8.4M+11.3%
BARCLAYS PLC#79 · 94,069 sh$8.4M+105.5%
F/m Investments#80 · 92,618 sh$8.2M-6.9%
PRUDENTIAL FINANCIAL#81 · 87,370 sh$7.8M+46.7%
FEDERATED HERMES#82 · 85,950 sh$7.6MNew
Granahan Investment Management#83 · 82,991 sh$7.4MNew
CITIGROUP#84 · 82,593 sh$7.3M+587.9%
WELLS FARGO & COMPANY#85 · 82,506 sh$7.3M+148.5%
HighVista Strategies#86 · 77,807 sh$6.9M-46.8%
MERCER GLOBAL ADVISORS#87 · 71,145 sh$6.3M+0.1%
B Group#88 · 70,000 sh$6.2M-30.0%
Trexquant Investment#89 · 67,007 sh$5.9MNew
Informed Momentum#90 · 60,393 sh$5.4MNew
SILVERARC CAPITAL MANAGEMENT#91 · 59,959 sh$5.3M-67.9%
PRINCIPAL FINANCIAL GROUP#92 · 59,747 sh$5.3M+1289.8%
Hudson Bay Capital Management#93 · 58,387 sh$5.2MNew
HealthInvest Partners AB#94 · 57,030 sh$5.1M-9.1%
RAYMOND JAMES FINANCIAL#95 · 53,627 sh$4.8M+171.5%
Susquehanna Portfolio Strategies#96 · 53,101 sh$4.7M0.0%
ALLIANCEBERNSTEIN L.P.#97 · 92,540 sh$4.7M+30.5%
ROYCE & ASSOCIATES#98 · 51,789 sh$4.6MNew
XTX Topco Ltd#99 · 50,483 sh$4.5M+106.6%
Monashee Investment Management#100 · 50,000 sh$4.4MNew

Funds that sold out of SYRE in Q2 2026 (21)

Held SYRE at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held SYRE in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
Fairmount Funds Management4,018,101 sh$202.7M
RA CAPITAL MANAGEMENT, L.P.1,621,620 sh$81.8M
BAKER BROS. ADVISORS1,000,000 sh$50.4M
Caligan Partners878,127 sh$44.3M
ExodusPoint Capital Management87,065 sh$4.4M
ALPS ADVISORS63,939 sh$3.2M
Assenagon Asset Management S.A.18,647 sh$940.6K
Carlyle Group9,620 sh$485.2K
RWC Asset Management LLP8,166 sh$411.9K
CAPSTONE INVESTMENT ADVISORS7,537 sh$380.2K
Scientech Research7,088 sh$357.5K
Arrowpoint Investment Partners (Singapore) Pte. Ltd.6,140 sh$309.7K
DeepCurrents Investment Group4,740 sh$239.1K
QUADRANT CAPITAL GROUP292 sh$56.3K
Patient Square Capital1,000 sh$50.4K
GROUP ONE TRADING, L.P.901 sh$45.4K
SUMMIT SECURITIES GROUP562 sh$28.3K
Delos Wealth Advisors250 sh$12.6K
MAI Capital Management13 sh$656.00
MassMutual Private Wealth & , FSB3 sh$151.00
TWIN PEAKS WEALTH ADVISORS3 sh$151.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.